Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)

NCT00842387 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00842387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00842387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2009
Enrollment
2,370 (estimated)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

esophagitis, heartburn, reflux, regurgitation